The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Erlotinib added to bevacizumab as maintenance therapy and health-related quality of life in patients with metastatic colorectal cancer: Results of the GERCOR DREAM phase III trial.
 
Amelie Anota
No Relationships to Disclose
 
Dewi Vernerey
Consulting or Advisory Role - Celgene; Janssen
 
Christophe Tournigand
Research Funding - Roche
 
Benoist Chibaudel
Honoraria - Sanofi
Consulting or Advisory Role - Lilly; Sanofi
Travel, Accommodations, Expenses - Amgen; Merck; Roche; Sanofi
 
Benoit Samson
Consulting or Advisory Role - Roche
 
Werner Scheithauer
Honoraria - Roche
Consulting or Advisory Role - Roche
Research Funding - Roche (Inst)
 
David Brusquant
No Relationships to Disclose
 
Thierry Andre
Honoraria - Amgen; Baxter; BAYER; Bristol-Myers Squibb; Lilly; Merck Serono; Roche/Genentech; Sanofi
Consulting or Advisory Role - Roche/Genentech
Travel, Accommodations, Expenses - Amgen; Roche/Genentech
 
Aimery De Gramont
Consulting or Advisory Role - Roche; Sanofi
 
Franck Bonnetain
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Eisai; IntegraGen; invectys; Merck Serono; NESTLE; Novartis; Roche
Research Funding - Roche (Inst)